Everything you need to know about Cardiac Diabetic PCD Franchise in India — investment (₹30,000–₹3 lakh), profit margins (20–40%), monopoly rights, required documents (Drug License + GST), MOQ, certifications, red flags, and how to apply — answered in one complete 2026 guide. Amplec Healthcare offers WHO-GMP & ISO certified cardiac-diabetic franchise with 400+ formulations, written monopoly rights, pan-India delivery, and full marketing support. Steady repeat prescriptions, 12–15% annual segment growth, 6–12 month ROI. Contact Amplec to check territory availability.